{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:54:58Z","timestamp":1792270498833,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejmech.2023.115226","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:12:30Z","timestamp":1677582750000},"page":"115226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)"],"prefix":"10.1016","volume":"251","author":[{"given":"Ahmed M.","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa Hatem","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Tajuddeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Bodem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Striffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bringmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-6922","authenticated-orcid":false,"given":"Usama Ramadan","family":"Abdelmohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115226_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115226_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-022-00584-8","article-title":"Wuhan market was epicentre of pandemic's start, studies suggest","volume":"603","author":"Maxmen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115226_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115226_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(20)30167-3","article-title":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","volume":"8","author":"Halpin","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-bioeng-110220-012203","article-title":"Deep learning and medical image analysis for COVID-19 diagnosis and prediction","volume":"24","author":"Liu","year":"2022","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.ejmech.2023.115226_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"For the Lifelines Corona Research Initiative, Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115226_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115860","article-title":"Protease targeted COVID-19 drug discovery and its challenges: insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors","volume":"29","author":"Amin","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00483-20","article-title":"Updated approaches against SARS-CoV-2, antimicrob","volume":"64","author":"Li","year":"2020","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2023.115226_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2023.115226_bib10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41591-021-01459-7","article-title":"Understanding COVID-19 vaccine hesitancy","volume":"27","author":"Machingaidze","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671263","article-title":"Current strategies of antiviral drug discovery for COVID-19","volume":"8","author":"Mei","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2023.115226_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"For the ACTT-1 study members, remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115226_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"On behalf of the Inhaled Interferon Beta COVID-19 Study Group, Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib15","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMc2205944","article-title":"For the EPIC-HR trial investigators, nirmatrelvir-ritonavir and viral load rebound in Covid-19","volume":"387","author":"Anderson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ejmech.2023.115226_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1039\/D1MD00066G","article-title":"A review of the latest research on Mpro targeting SARS-COV inhibitors","volume":"12","author":"Yang","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115226_bib20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/D0SC04942E","article-title":"Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease","volume":"12","author":"Pavlova","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2023.115226_bib21","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/molecules26092654","article-title":"Olive-derived triterpenes suppress SARS COV-2 main protease: a promising scaffold for future therapeutics","volume":"26","author":"Alhadrami","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115226_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1529\/biophysj.106.091736","article-title":"Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride","volume":"92","author":"Chang","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2023.115226_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/acsptsci.0c00074","article-title":"Potential therapeutic agents and associated bioassay data for COVID-19 and related human coronavirus infections","volume":"3","author":"Zhou","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2023.115226_bib24","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/s41467-022-29915-z","article-title":"Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease","volume":"13","author":"Kneller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115226_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115226_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202205858","article-title":"Comprehensive fragment screening of the SARS\u2010CoV\u20102 proteome explores novel chemical space for drug development","volume":"134","author":"Berg","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2023.115226_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/acs.accounts.2c00735","article-title":"SARS-CoV-2 main protease drug design, assay development, and drug resistance studies","volume":"56","author":"Tan","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115226_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200440","article-title":"Recent drug development and medicinal chemistry approaches for the treatment of SARS\u2010CoV\u20102 infection and COVID\u201019","volume":"17","author":"Ghosh","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115226_bib29","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/jo00100a042","article-title":"novel antimalarial alkaloids from Ancistrocladus korupensis","volume":"59","author":"Hallock","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/C9NP00024K","article-title":"Dimeric naphthylisoquinoline alkaloids: polyketide-derived axially chiral bioactive quateraryls","volume":"36","author":"Lombe","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2023.115226_bib31","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1039\/D1NP00020A","article-title":"N,C-Coupled naphthylisoquinoline alkaloids: a versatile new class of axially chiral natural products","volume":"38","author":"Tajuddeen","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2023.115226_bib32","doi-asserted-by":"crossref","unstructured":"D. Feineis, G. Bringmann, in: A.D. Kinghorn, H. Falk, S. Gibbons, Y. Asakawa, J.-K. Liu, V.M. Dirsch (Eds.), Asian Ancistrocladus lianas as creative producers of naphthylisoquinoline alkaloids, in: Progress in the Chemistry of Organic Natural Products, vol. 119, Springer, Cham, Heidelberg, New York, Dordrecht, London, 2023, pp. 1\u2013335.","DOI":"10.1007\/978-3-031-10457-2_1"},{"key":"10.1016\/j.ejmech.2023.115226_bib33","first-page":"1","volume":"vol. 82","author":"Bringmann","year":"2001"},{"key":"10.1016\/j.ejmech.2023.115226_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/cr100155e","article-title":"Atroposelective total synthesis of axially chiral biaryl natural products","volume":"111","author":"Bringmann","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115226_bib35","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1021\/acs.accounts.2c00432","article-title":"The stereoselective total synthesis of axially chiral naphthylisoquinoline alkaloids","volume":"55","author":"Tajuddeen","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115226_bib36","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1128\/AAC.41.11.2533","article-title":"Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against Plasmodium berghei in vivo","volume":"41","author":"Fran\u00e7ois","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115226_bib37","first-page":"1","volume":"vol. 117","author":"Kingston","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115226_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12936-019-3026-1","article-title":"Antiplasmodial natural products: an update","volume":"18","author":"Tajuddeen","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2023.115226_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpddr.2020.05.003","article-title":"Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products","volume":"13","author":"Moyo","year":"2020","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115226_bib40","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1021\/acs.orglett.7b03473","article-title":"Antiprotozoal spirombandakamines A1 and A2, fused naphthylisoquinoline dimers from a Congolese Ancistrocladus plant","volume":"19","author":"Lombe","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.115226_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/AAC.00936-06","article-title":"Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major","volume":"51","author":"Ponte-Sucre","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115226_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/jm801084u","article-title":"Structure\u2013activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts","volume":"52","author":"Ponte-Sucre","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1099\/jmm.0.014241-0","article-title":"Alterations to the structure of Leishmania major induced by N-arylisoquinolines correlate with compound accumulation and disposition","volume":"59","author":"Ponte-Sucre","year":"2010","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115226_bib44","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/gb-2011-12-3-r24","article-title":"Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells","volume":"12","author":"Cecil","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2023.115226_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-8741(96)01459-6","article-title":"Larvicidal activity of the naphthylisoquinoline alkaloid dioncophylline A against the malaria vector Anopheles stephensi","volume":"54","author":"Fran\u00e7ois","year":"1996","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2023.115226_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/s-2006-957970","article-title":"Molluscicidal activity of naphthylisoquinoline alkaloids from Triphyophyllum and Ancistrocladus species","volume":"62","author":"Bringmann","year":"1996","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-957495","article-title":"Molluscicidal activity (Biomphalaria glabrata) of dioncophylline A: structure-activity investigations","volume":"64","author":"Bringmann","year":"1998","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2023.115226_bib48","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/S0031-9422(00)97535-6","article-title":"Feeding deterrency and growth retarding activity of the naphthylisoquinoline alkaloid dioncophylline A against Spodoptera littoralis","volume":"31","author":"Bringmann","year":"1992","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115226_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/np960707s","article-title":"Dioncophylline A as a growth-retarding agent against the herbivorous insect Spodoptera littoralis: structure\u2013activity relationships","volume":"60","author":"Bringmann","year":"1997","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115226_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2020.109177","article-title":"Naphthylisoquinoline alkaloids and their synthetic analogs as potent novel inhibitors against Babesia canis in vitro","volume":"283","author":"Bringmann","year":"2020","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115226_bib51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/acs.jnatprod.6b00967","article-title":"Dioncophyllines C2, D2, and F and related naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus ileboensis with potent activities against Plasmodium falciparum and against multiple myeloma and leukemia cell lines","volume":"80","author":"Li","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115226_bib52","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1021\/acs.jnatprod.8b00733","article-title":"Ancistrolikokine E3, a 5,8\u2032-coupled naphthylisoquinoline alkaloid, eliminates the tolerance of cancer cells to nutrition starvation by inhibition of the Akt\/mTOR\/autophagy signaling pathway","volume":"81","author":"Awale","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115226_bib53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acs.jnatprod.9b01168","article-title":"unprecedented seco-naphthylisoquinoline alkaloids from the roots of Ancistrocladus abbreviatus, with apoptosis-inducing potential against HeLa cancer cells","volume":"83","author":"Fayez","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115226_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115950","article-title":"Ancistrobrevidines A-C and related naphthylisoquinoline alkaloids with cytotoxic activities against HeLa and pancreatic cancer cells, from the liana Ancistrocladus abbreviatus","volume":"30","author":"Fayez","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115297","article-title":"Induction of apoptosis in breast cancer cells by naphthylisoquinoline alkaloids","volume":"409","author":"Kushwaha","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115226_bib56","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/jm00038a003","article-title":"Anti-HIV michellamines from Ancistrocladus korupensis","volume":"37","author":"Boyd","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib57","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1021\/jm00116a011","article-title":"Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2","volume":"34","author":"Manfredi","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.39.2.484","article-title":"Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms","volume":"39","author":"McMahon","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115226_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.phytochem.2016.04.005","article-title":"HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis","volume":"128","author":"Bringmann","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115226_bib60","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/antibiotics10050542","article-title":"Cnicin as an anti-SARS-CoV-2: an integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics","volume":"10","author":"Alhadrami","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2023.115226_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/md20030163","article-title":"Neoechinulin A as a promising SARS-CoV-2 Mpro inhibitor: in vitro and in silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors","volume":"20","author":"Alhadrami","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2023.115226_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/md20030179","article-title":"Aurasperone A inhibits SARS CoV-2 in vitro: an integrated in vitro and in silico study","volume":"20","author":"ElNaggar","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2023.115226_bib63","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/antibiotics10040420","article-title":"Sinapic acid suppresses SARS CoV-2 replication by targeting its envelope protein","volume":"10","author":"Orfali","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2023.115226_bib64","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/antibiotics10111278","article-title":"Efficacy of ceftazidime and cefepime in the management of COVID-19 patients: single center report from Egypt","volume":"10","author":"Eid","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2023.115226_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-4-445","article-title":"AUDocker LE: A GUI for virtual screening with AUTODOCK Vina","volume":"4","author":"Sandeep","year":"2011","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejmech.2023.115226_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23751-3","article-title":"Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease","volume":"12","author":"Su","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115226_bib67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/acs.jcim.1c00851","article-title":"High-throughput virtual screening and validation of a SARS-CoV-2 main protease noncovalent inhibitor","volume":"62","author":"Clyde","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115226_bib68","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1021\/acs.jcim.1c00159","article-title":"Benchmark of popular free energy approaches revealing the inhibitors binding to SARS-CoV-2 Mpro","volume":"61","author":"Ngo","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115226_bib69","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1021\/ja100259r","article-title":"Single-molecule pulling simulations can discern active from inactive enzyme inhibitors","volume":"132","author":"Colizzi","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115226_bib70","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2023.115226_bib71","doi-asserted-by":"crossref","first-page":"53740","DOI":"10.1039\/C7RA11200A","article-title":"Ancistrolikokines E\u2013H and related 5,8\u2032-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko with antiausterity activities against PANC-1 human pancreatic cancer cells","volume":"7","author":"Fayez","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115226_bib72","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.fitote.2018.11.006","article-title":"Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells","volume":"131","author":"Fayez","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2023.115226_bib73","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0040-4039(00)94588-X","article-title":"On the structure of the Dioncophyllaceae alkaloids dioncophylline A (\u201ctriphyophylline\u201d) and \u201cO-methyl-triphyophylline\u201d","volume":"31","author":"Bringmann","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2023.115226_bib74","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0031-9422(91)84235-K","article-title":"Dioncopeltine A and dioncolactone A: alkaloids from Triphyophyllum peltatum","volume":"30","author":"Bringmann","year":"1991","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115226_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0031-9422(97)00512-8","article-title":"Ancistrobertsonine A and related naphthylisoquinoline alkaloids from Ancistrocladus robertsoniorum","volume":"47","author":"Bringmann","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115226_bib76","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1016\/S0031-9422(00)97576-9","article-title":"Dioncophylline C from the roots of Triphyophyllum peltatum, the first 5,1\u2032-coupled Dioncophyllaceae alkaloid","volume":"31","author":"Bringmann","year":"1992","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115226_bib77","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/jo991634v","article-title":"First atropo-divergent total synthesis of the antimalarial korupensamines A and B by the \u201clactone method\u201d","volume":"65","author":"Bringmann","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib78","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005659","article-title":"OpenMM 7: rapid development of high performance algorithms for molecular dynamics","volume":"13","author":"Eastman","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2023.115226_bib80","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2023.115226_bib81","series-title":"Chemical Biology. Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx in","volume":"vol. 1263","author":"Dallakyan","year":"2015"},{"key":"10.1016\/j.ejmech.2023.115226_bib82","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/ph14060541","article-title":"Scaffold hopping of \u03b1-rubromycin enables direct access to FDA-approved cromoglicic acid as a SARS-CoV-2 MPro inhibitor","volume":"14","author":"Alhadrami","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115226_bib83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/bs.arcc.2017.06.005","article-title":"Gaussian accelerated molecular dynamics: theory, implementation, and applications","volume":"13","author":"Miao","year":"2017","journal-title":"Annu. Rep. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115226_bib84","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1038\/s41598-021-85049-0","article-title":"The serotonin reuptake inhibitor fluoxetine inhibits SARS-CoV-2 in human lung tissue","volume":"11","author":"Zimniak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115226_bib85","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/cells11162532","article-title":"The acid ceramidase is a SARS-CoV-2 host factor","volume":"11","author":"Geiger","year":"2022","journal-title":"Cells"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:47:21Z","timestamp":1759330041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423001927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":85,"alternative-id":["S0223523423001927"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115226","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115226"}}